Glipizide
NDC 16714-894, Glipizide, tablet, extended release, from Northstar Rx LLC..
- Product NDC
- 16714-894
- Status
- Listed
- Labeler
- Northstar Rx LLC.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203499
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16714-894 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE2.5 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16714-894-01 | 16714089401 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-894-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/915636a4-092e-4e2e-9bc0-0d387d996977NADAC price for package 16714089401
GET /v1/drugs/nadac/16714089401
Use it
Look up 16714-894 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16714-894 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16714-894. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.